Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 705 (USA) (Dr. Muller)
· consented 2013-11-27
Adverse events
1
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-25 (study day 29.0); relationship: POSSIBLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.